Antiphospholipid antibodies in migraine

Area of Science:

• Neurology
• Immunology
• Rheumatology

Background:

• Migraine is a common neurological disorder.
• Antiphospholipid antibodies (APA) are associated with autoimmune conditions and thrombosis.
• The role of APA in migraine pathogenesis is not well understood.

Purpose of the Study:

• To investigate the prevalence of serum APA in migraine patients.
• To compare APA levels between migraine patients and healthy controls.
• To evaluate the clinical significance of APA in migraine.

Main Methods:

• Serum samples were collected from 35 migraine patients and 75 controls.
• Antiphospholipid antibodies (APA) were measured using serological assays.
• Clinical features and follow-up data were collected for all participants.

Main Results:

• APA were detected in 5 out of 35 migraine patients (p = 0.003).
• No APA were found in the 75 controls.
• Clinical characteristics and one-to-two-year follow-up showed no significant differences or complications related to APA presence.

Conclusions:

• APA are present in a subset of migraine patients.
• APA do not appear to be a significant factor in the pathogenesis or long-term course of migraine in otherwise healthy individuals.
• Further research may be needed to clarify the specific role, if any, of APA in certain migraine subtypes.